Chih-Yi Liu

Dr. Chih-Yi Liu

Sijhih Cathay General Hospital
+1
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
YLYu-Chen Lee
Yu-Chen Lee
CLChih-Yi Liu
Chih-Yi Liu
CLChia-Long Lee
Chia-Long Lee
RZRuo-Han Zhang
Ruo-Han Zhang
CHChi-Jung Huang
Chi-Jung Huang
Ting-lin YenTing-lin Yen
Ting-lin Yen
Periodontal disease (PD) is one of the most prevalent disorders globally and is strongly associated with many other diseases. Inflammatory bowel disease (IBD), an inflammatory condition of the colon and the small intestine, is reported to be associated with PD through undetermined mechanisms. We analyzed taxonomic assignment files from the Crohn’s Disease Viral and Microbial Metagenome Project (PRJEB3206). The abundance of Porphyromonadaceae in fecal samples was significantly different between patients with Crohn’s disease and control volunteers. Dextran sulfate sodium was used to induce colitis in mice to reveal the effect of this periodontopathic pathogen in vivo. After intrarectal implantation of Porphyromonas gingivalis (Pg)—the primary pathogen causing PD—the disease activity index score, colonic epithelial loss, and inflammatory cell infiltration were intensified. In addition, tumor necrosis factor-α and interleukin-6 showed the highest levels in Pg-infected colons. This revealed the importance of Pg in the exacerbation of IBD. Thus, simultaneous treatment of PD should be considered for people with IBD. Moreover, implantation of Pg in the rectum worsened the clinical symptoms of colitis in mice. Because Pg participates in the pathogenesis of IBD, reducing the chances of it entering the intestine might prevent the worsening of this disorder.

17 May 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Jiun-Wen GuoJiun-Wen Guo
Jiun-Wen Guo
YCYu-Pin Cheng
Yu-Pin Cheng
CLChih-Yi Liu
Chih-Yi Liu
HTHaw-Yueh Thong
Haw-Yueh Thong
CHChi-Jung Huang
Chi-Jung Huang
SJShiou-Hwa Jee
Shiou-Hwa Jee
Psoriasis is a chronic inflammatory skin disorder with a pathogenesis involving the interleukin-23/interleukin-17 axis. Salvianolic acid B exerts several pharmacological effects, such as antioxidation, anti-inflammation, and antitumor effects. The anti-psoriatic effects of salvianolic acid B have not been reported. In this study, we aimed to determine the optimum vehicle for salvianolic acid B, investigate its therapeutic effect on psoriatic-like skin conditions, and explore its underlying mechanisms of action. BALB/c mice were administered topical imiquimod to induce psoriasis-like skin and were then randomly assigned to control, vehicle control, salvianolic acid B in vehicles, and 0.25% desoximetasone ointment treatment groups. Barrier function, cytokine expression, histology assessment, and disease severity were evaluated. The results showed that salvianolic acid B-containing microemulsion alleviated disease severity, reduced acanthosis, and inhibited interleukin-23/interleukin-17 (IL-23/IL-17) cytokines, epidermal proliferation, and increased skin hydration. Our study suggests that salvianolic acid B represents a possible new therapeutic drug for the treatment of psoriasis. In addition, such formulation could obtain high therapeutic efficacy in addition to providing sufficient hydration for dry skin.

20 July 2020 in Cancers
Verified
Journal Article
Open access
PDF file
WLWei-An Lai
Wei-An Lai
CLChih-Yi Liu
Chih-Yi Liu
SLShih-Yao Lin
Shih-Yao Lin
Chien-Chin ChenChien-Chin Chen
Chien-Chin Chen
JHJen-Fan Hang
Jen-Fan Hang
Anaplastic thyroid carcinoma (ATC) is rare but highly aggressive. We investigated the association of selected driver mutations, including BRAF, RAS, PIK3CA, TERT promoter, TP53, POLE, and mismatch repair deficiency (MMR-D) with the clinicopathological features of ATC to identify prognostic and predictive biomarkers. Thirty-nine retrospective cases from pathology archives were enrolled for clinicopathology analysis and immunohistochemistry, and 27 cases had sufficient specimens for further molecular testing using targeted next-generation sequencing and mass spectrometry. BRAFV600E and RAS mutations were identified in 25.9% and 40.7% of ATC, respectively. BRAFV600E mutation was significantly associated with coexisting papillary thyroid carcinoma (p = 0.009) and RAS mutations with female gender (p = 0.012). In univariant analysis, the non-BRAF/RAS tumors were significantly associated with the presence of a sarcomatoid pattern (p = 0.045). PIK3CA, TERT promoter, and TP53 mutations were identified in 14.8%, 81.5%, and 70.4% of cases, respectively. No MMR-D or POLE mutations were detected. In survival analyses, RAS and PIK3CA mutations were significantly associated with inferior outcomes (p = 0.03 and p = 0.006, respectively). In conclusion, driver mutations in ATC are associated with distinct clinicopathological features. RAS and PIK3CA mutations were negative predictors for patient survival. Emerging therapeutic agents targeting BRAF, RAS, and PI3 kinase may benefit a substantial proportion of ATC patients.

4 December 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
YWYen-Chieh Wang
Yen-Chieh Wang
WKWei-Chi Ku
Wei-Chi Ku
CLChih-Yi Liu
Chih-Yi Liu
YCYU CHE CHENG
YU CHE CHENG
CCChih-Cheng Chien
Chih-Cheng Chien
CHChi-Jung Huang
Chi-Jung Huang
In bladder cancer, urothelial carcinoma is the most common histologic subtype, accounting for more than 90% of cases. Pathogenic effects due to the dysbiosis of gut microbiota are localized not only in the colon, but also in regulating bladder cancer distally. Butyrate, a short-chain fatty acid produced by gut microbial metabolism, is mainly studied in colon diseases. Therefore, the resolution of the anti-cancer effects of butyrate-producing microbes on bladder urothelial cells and knowledge of the butyrate-responsive molecules must have clinical significance. Here, we demonstrate a correlation between urothelial cancer of the bladder and Butyricicoccus pullicaecorum. This butyrate-producing microbe or their metabolite, butyrate, mediated anti-cancer effects on bladder urothelial cells by regulating cell cycle, cell growth, apoptosis, and gene expression. For example, a tumor suppressor against urothelial cancer of the bladder, bladder cancer-associated protein, was induced in butyrate-treated HT1376 cells, a human urinary bladder cancer cell line. In conclusion, urothelial cancer of the bladder is a significant health problem. To improve the health of bladder urothelial cells, supplementation of B. pullicaecorum may be necessary and can further regulate butyrate-responsive molecular signatures.

15 March 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
CLChih-Yi Liu
Chih-Yi Liu
BCBo-Jung Chen
Bo-Jung Chen
SCShih-Sung Chuang
Shih-Sung Chuang
Primary effusion lymphoma (PEL) is defined by the WHO classification as a large B-cell neoplasm without detectable tumor masses. It is universally associated with HHV8, with most cases occurring in the setting of immunodeficiency such as HIV infection, and a poor prognosis. Morphologically, the neoplastic cells range from immunoblastic, plasmablastic, to anaplastic; and phenotypically, most cases express plasma cell but not B-cell markers, i.e., plasmablastic. During the past decade, primary HHV8-negative effusion lymphoma has been reported. Such cases were considered in the WHO classification scheme as effusion-based lymphoma. We performed a systemic review of 167 HHV8-negative effusion lymphomas from the literature and found that only 42% were associated with a fluid overload state, and with low rates of HIV (6%) or EBV (21%) infection. Furthermore, most patients are old (or immunosenescent) with underlying medical conditions/comorbidities, most neoplasms are of B-cell phenotype, and the outcome is more favorable than that of HHV8-positive PEL. These distinctive findings supported our prior proposal of designating these HHV8-negative cases as type II PEL, in contrast to the classic or type I PEL as defined by the WHO. Furthermore, we propose an algorithmic approach for the diagnosis of PEL and its mimickers.

15 May 2004 in Journal of Applied Physics
Verified
Journal Article
Closed access
PDF file
CLChih-Yi Liu
Chih-Yi Liu
BCBo-Yang Chen
Bo-Yang Chen
TTTseung-Yuen Tseng
Tseung-Yuen Tseng
SrTiO3 (STO) thin films were deposited on p-type silicon substrate by radio-frequency (rf) magnetron sputtering in an Ar–O2 and Ar–N2 mixed ambient to form metal/insulator/semiconductor (MIS) structure. We found the Schottky emission and Fowler–Nordheim tunneling mechanisms as responsible for the leakage current in the STO-based MIS structures at low and high electric fields under negative bias voltage, respectively. On the other hand, it was also observed that the generation current dominated the leakage mechanism at the high electric field under positive bias voltage due to the highly leaky insulator and lack of electrons. To maintain the leakage current at the higher electric field, the depletion width would broaden to generate more electrons, which is called deep depletion. Therefore, deep depletion was induced by high leakage current density under positive bias voltage. We also investigated the correlation between deep depletion and the leakage mechanism in STO-based gate dielectric capacitors under positive bias voltage to extract the generation lifetime of silicon substrates. The extracted generation lifetime can be used to examine the quality of silicon substrates after different processing conditions.